相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Brain mapping in multiple sclerosis: Lessons learned about the human brain
Massimo Filippi et al.
NEUROIMAGE (2019)
Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
Nelly Siller et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
Nelly Siller et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor
Georgina Arrambide et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm
Andrew J. Solomon et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop
Maria Pia Amato et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
Fredrik Piehl et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor
Georgina Arrambide et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm
Andrew J. Solomon et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop
Maria Pia Amato et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
Fredrik Piehl et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis
Sabina Luchetti et al.
ACTA NEUROPATHOLOGICA (2018)
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis
Roberta Magliozzi et al.
ANNALS OF NEUROLOGY (2018)
Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies
Pietro Maggi et al.
ANNALS OF NEUROLOGY (2018)
T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention
Jamie van Langelaar et al.
BRAIN (2018)
The value of oligoclonal bands in the multiple sclerosis diagnostic criteria
Georgina Arrambide et al.
BRAIN (2018)
The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+T lymphocytes and B cells
Joana Machado-Santos et al.
BRAIN (2018)
Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome
Clara Matute-Blanch et al.
BRAIN (2018)
The Evidence for Dietary Interventions and Nutritional Supplements as Treatment Options in Multiple Sclerosis: a Review
Leah J. Mische et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2018)
Can Optical Coherence Tomography Be Used to Guide Treatment Decisions in Adult or Pediatric Multiple Sclerosis?
Jeffrey Lambe et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2018)
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
S. Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis
Hanane Touil et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Randomised controlled trial of a self-guided online fatigue intervention in multiple sclerosis
Jana Poettgen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
Raja Kapoor et al.
LANCET NEUROLOGY (2018)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study
Massimo Filippi et al.
LANCET NEUROLOGY (2018)
Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations
Nicola De Stefano et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
Xavier Montalban et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Reassessing B cell contributions in multiple sclerosis
Rui Li et al.
NATURE IMMUNOLOGY (2018)
The current role of MRI in differentiating multiple sclerosis from its imaging mimics
Ruth Geraldes et al.
NATURE REVIEWS NEUROLOGY (2018)
Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis
Alexander Rae-Grant et al.
NEUROLOGY (2018)
Multiple Sclerosis: Mechanisms and Immunotherapy
Clare Baecher-Allan et al.
NEURON (2018)
IL-1β enables CNS access to CCR2hi monocytes and the generation of pathogenic cells through GM-CSF released by CNS endothelial cells
Alexandre Pare et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
People with multiple sclerosis report significantly worse symptoms and health related quality of life than the US general population as measured by PROMIS and NeuroQoL outcome measures
Dagmar Amtmann et al.
DISABILITY AND HEALTH JOURNAL (2018)
A Review of the Current Evidence on Gadolinium Deposition in the Brain
Richard Pullicino et al.
CLINICAL NEURORADIOLOGY (2018)
Effector T Cells in Multiple Sclerosis
Belinda J. Kaskow et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Regulatory T Cells: From Discovery to Autoimmunity
Alexandra Kitz et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Multiple Sclerosis Pathology
Hans Lassmann
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Association of Retinal Ganglion Cell Layer Thickness With Future Disease Activity in Patients With Clinically Isolated Syndrome
Hanna G. Zimmermann et al.
JAMA NEUROLOGY (2018)
Comparative Effectiveness of Rituximab and Other Initial Treatment Choices for Multiple Sclerosis
Mathias Granqvist et al.
JAMA NEUROLOGY (2018)
Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations
Nicola De Stefano et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
Xavier Montalban et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Worldwide prevalence of familial multiple sclerosis: A systematic review and meta-analysis
Mohammad Hossein Harirchian et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis
Peter J. Darlington et al.
FRONTIERS IN IMMUNOLOGY (2018)
Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis
Ivan Jelcic et al.
CELL (2018)
MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder
Ram Narayan et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Vitamin D and Multiple Sclerosis: A Comprehensive Review
Martina B. Sintzel et al.
NEUROLOGY AND THERAPY (2018)
Axonal loss in the multiple sclerosis spinal cord revisited
Natalia Petrova et al.
BRAIN PATHOLOGY (2018)
Safety and preliminary efficacy of deep transcranial magnetic stimulation in MS-related fatigue
Gunnar Gaede et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Multicenter reliability of semiautomatic retinal layer segmentation using OCT
Timm Oberwahrenbrock et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Genome-wide association studies of multiple sclerosis (vol 7, e1018, 2018)
Chris Cotsapas et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2018)
Anti-LINGO-1 has no detectable immunomodulatory effects in preclinical and phase 1 studies
Ann Ranger et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome
W. J. Brownlee et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Tomas Olsson et al.
NATURE REVIEWS NEUROLOGY (2017)
Brain MRI atrophy quantification in MS From methods to clinical application
Maria A. Rocca et al.
NEUROLOGY (2017)
Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome
W. J. Brownlee et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Multiple sclerosis: Frequency, cost, and economic burden in the United States
Alex Y. Chen et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2017)
Antibody-Independent Function of Human B Cells Contributes to Antifungal T Cell Responses
Rui Li et al.
JOURNAL OF IMMUNOLOGY (2017)
B cells from patients with multiple sclerosis. induce cell death via apoptosis in neurons in vitro
Robert P. Lisak et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Excess mortality among patients with multiple sclerosis in Denmark has dropped significantly over the past six decades: a population based study
Nils Koch-Henriksen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study
Hanne Marie Boe Lunde et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Cortical Remyelination Is Heterogeneous in Multiple Sclerosis
Eva M. M. Strijbis et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2017)
NEDA treatment target? No evident disease activity as an actionable outcome in practice
Natalie E. Parks et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Evolving concepts in the treatment of relapsing multiple sclerosis
Giancarlo Comi et al.
LANCET (2017)
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial
Ari J. Green et al.
LANCET (2017)
Diagnosis of multiple sclerosis: progress and challenges
Wallace J. Brownlee et al.
LANCET (2017)
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
Axel Petzold et al.
LANCET NEUROLOGY (2017)
Exercise in patients with multiple sclerosis
Robert W. Motl et al.
LANCET NEUROLOGY (2017)
Targets of therapy in progressive MS
Hans Lassmann
MULTIPLE SCLEROSIS JOURNAL (2017)
New insights into the burden and costs of multiple sclerosis in Europe
Gisela Kobelt et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
No evident disease activity: The use of combined assessments in the management of patients with multiple sclerosis
Gavin Giovannoni et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Comorbidity in multiple sclerosis: implications for patient care
Ruth Ann Marrie
NATURE REVIEWS NEUROLOGY (2017)
Treatment decisions in multiple sclerosis - insights from real-world observational studies
Maria Trojano et al.
NATURE REVIEWS NEUROLOGY (2017)
Older Age at Multiple Sclerosis Onset Is an Independent Factor of Poor Prognosis: A Population-Based Cohort Study
Francis Guillemin et al.
NEUROEPIDEMIOLOGY (2017)
Alemtuzumab CARE-MS I 5-year follow-up Durable efficacy in the absence of continuous MS therapy
Eva Havrdova et al.
NEUROLOGY (2017)
Fast multiple sclerosis progression in North Africans Both genetics and environment matter
Youssef Sidhom et al.
NEUROLOGY (2017)
Alemtuzumab CARE-MS II 5-year follow-up
Alasdair J. Coles et al.
NEUROLOGY (2017)
Autologous hematopoietic stem cell transplantation in multiple sclerosis A meta-analysis
Maria Pia Sormani et al.
NEUROLOGY (2017)
Mortality trends for multiple sclerosis patients in Sweden from 1968 to 2012
Sarah Burkill et al.
NEUROLOGY (2017)
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
S. L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
X. Montalban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years
Sergio E. Baranzini et al.
TRENDS IN GENETICS (2017)
Dominant Optic Atrophy and Leber's Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches
Bo Young Chun et al.
SEMINARS IN PEDIATRIC NEUROLOGY (2017)
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
Paolo A. Muraro et al.
JAMA NEUROLOGY (2017)
Targets of therapy in progressive MS
Hans Lassmann
MULTIPLE SCLEROSIS JOURNAL (2017)
New insights into the burden and costs of multiple sclerosis in Europe
Gisela Kobelt et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
No evident disease activity: The use of combined assessments in the management of patients with multiple sclerosis
Gavin Giovannoni et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Vitamin D and multiple sclerosis: An update
Charles Pierrot-Deseilligny et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
Long-term disability progression in primary progressive multiple sclerosis: a 15-year study
Maria A. Rocca et al.
BRAIN (2017)
Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)
W. Oliver Tobin et al.
BRAIN (2017)
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response
Tomas Kalincik et al.
BRAIN (2017)
Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosis
Tobias Zrzavy et al.
BRAIN (2017)
Treatment of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines
Shachar Moshe Aharony et al.
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2017)
Number Needed to Treat in Multiple Sclerosis Clinical Trials
Macaulay Okwuokenye et al.
NEUROLOGY AND THERAPY (2017)
Pediatric multiple sclerosis
Anusha K. Yeshokumar et al.
CURRENT OPINION IN NEUROLOGY (2017)
Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis
Giulio Disanto et al.
ANNALS OF NEUROLOGY (2017)
Time correlation between mononucleosis and initial symptoms of MS
John Endriz et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis
Tanja Juergens et al.
BRAIN (2016)
No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy
Alfredo Damasceno et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy
Alfredo Damasceno et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions
P. Brenner et al.
ACTA NEUROLOGICA SCANDINAVICA (2016)
MRI and neurophysiological measures to predict course, disability and treatment response in multiple sclerosis
Letizia Leocani et al.
CURRENT OPINION IN NEUROLOGY (2016)
TREATING MULTIPLE SCLEROSIS WITH CLADRIBINE
C. Alvarez-Gonzalez et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
Fred Lublin et al.
LANCET (2016)
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial
Rhian Raftopoulos et al.
LANCET NEUROLOGY (2016)
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
Massimo Filippi et al.
LANCET NEUROLOGY (2016)
Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial
Jeffrey A. Cohen et al.
LANCET NEUROLOGY (2016)
A Multidimensional Computerized Adaptive Short-Form Quality of Life Questionnaire Developed and Validated for Multiple Sclerosis The MusiQoL-MCAT
Pierre Michel et al.
MEDICINE (2016)
Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study
Axel Petzold et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions
Niraj Mistry et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Inclusion of brain volume loss in a revised measure of no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosis
Ludwig Kappos et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative
Pascal Sati et al.
NATURE REVIEWS NEUROLOGY (2016)
The APOSTEL recommendations for reporting quantitative optical coherence tomography studies
Andres Cruz-Herranz et al.
NEUROLOGY (2016)
Recommendations for observational studies of comorbidity in multiple sclerosis
Ruth Ann Marrie et al.
NEUROLOGY (2016)
The challenge of comorbidity in clinical trials for multiple sclerosis
Ruth Ann Marrie et al.
NEUROLOGY (2016)
The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study
Andrew J. Solomon et al.
NEUROLOGY (2016)
Neurofilament light chain level is a weak risk factor for the development of MS
Georgina Arrambide et al.
NEUROLOGY (2016)
Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis
Tingting Zhang et al.
NEUROLOGY (2016)
Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update
Alberto Ascherio et al.
SEMINARS IN NEUROLOGY (2016)
Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells
Francesca Ronchi et al.
NATURE COMMUNICATIONS (2016)
Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study
Ludwig Kappos et al.
JAMA NEUROLOGY (2016)
Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study
Axel Petzold et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions
Niraj Mistry et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Inclusion of brain volume loss in a revised measure of no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosis
Ludwig Kappos et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis
K. M. Fiest et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
Brain health: time matters in multiple sclerosis
Gavin Giovannoni et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue
Christian Veauthier et al.
EPMA JOURNAL (2016)
Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society
DE Moulin et al.
Pain Research & Management (2016)
Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis
Melania Spadaro et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
The topographical model of multiple sclerosis A dynamic visualization of disease course
Stephen C. Krieger et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Melanoma cell adhesion molecule-positive CD8 T lymphocytes mediate central nervous system inflammation
Catherine Larochelle et al.
ANNALS OF NEUROLOGY (2015)
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque
Josa M. Frischer et al.
ANNALS OF NEUROLOGY (2015)
Dynamics of Retinal Injury after Acute Optic Neuritis
Inigo Gabilondo et al.
ANNALS OF NEUROLOGY (2015)
Defining high, medium and low impact prognostic factors for developing multiple sclerosis
Mar Tintore et al.
BRAIN (2015)
Two Multiple Sclerosis Quality-of-Life Measures: Comparison in a National Sample
Fraser Moore et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2015)
Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy
Javad Rasouli et al.
JOURNAL OF IMMUNOLOGY (2015)
Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis
Tessa Dhaeze et al.
JOURNAL OF IMMUNOLOGY (2015)
ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis
Robert C. Sergott et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis
Maria A. Rocca et al.
LANCET NEUROLOGY (2015)
Progressive multiple sclerosis 1 Pathological mechanisms in progressive multiple sclerosis
Don H. Mahad et al.
LANCET NEUROLOGY (2015)
Antibodies to the inward rectifying potassium channel 4.1 in multiple sclerosis: different methodologies-conflicting results?
Bernhard Hemmer
MULTIPLE SCLEROSIS JOURNAL (2015)
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
J. Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort
Immy A. Ketelslegers et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
M. Alba Mane Martinez et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
Ruth Ann Marrie et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau et al.
NATURE (2015)
MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process
Alex Rovira et al.
NATURE REVIEWS NEUROLOGY (2015)
Body fluid biomarkers for multiple sclerosis-the long road to clinical application
Charlotte E. Teunissen et al.
NATURE REVIEWS NEUROLOGY (2015)
Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions
Jorge Ivan Alvarez et al.
NEUROBIOLOGY OF DISEASE (2015)
Clinical/Scientific Notes
Nicola De Stefano et al.
NEUROLOGY (2015)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
Jens Kuhle et al.
NEUROLOGY (2015)
Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
L. Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy
Rui Li et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis
Yonghao Cao et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study
Lauren E. Mokry et al.
PLOS MEDICINE (2015)
Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort
Dalia L. Rotstein et al.
JAMA NEUROLOGY (2015)
Antibodies to the inward rectifying potassium channel 4.1 in multiple sclerosis: different methodologies-conflicting results?
Bernhard Hemmer
MULTIPLE SCLEROSIS JOURNAL (2015)
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
J. Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort
Immy A. Ketelslegers et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
M. Alba Mane Martinez et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
Ruth Ann Marrie et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Remyelination Therapy in Multiple Sclerosis
Danielle E. Harlow et al.
FRONTIERS IN NEUROLOGY (2015)
Vision and vision-related outcome measures in multiple sclerosis
Laura J. Balcer et al.
BRAIN (2015)
Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria
S. Schippling et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study
Anat Achiron et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Therapeutic Intervention in Multiple Sclerosis with Alpha B-Crystallin: A Randomized Controlled Phase IIa Trial
Johannes M. van Noort et al.
PLOS ONE (2015)
Towards the implementation of 'no evidence of disease activity' in multiple sclerosis treatment: the multiple sclerosis decision model
Martin Stangel et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2015)
Acute optic neuritis Unmet clinical needs and model for new therapies
Steven L. Galetta et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
JAML mediates monocyte and CD8 T cell migration across the brain endothelium
Jorge Ivan Alvarez et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine
Julia Pakpoor et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Immunopathology of multiple sclerosis
Calliope A. Dendrou et al.
NATURE REVIEWS IMMUNOLOGY (2015)
MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
Patrick Waters et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Treatment Effect on Brain Atrophy Correlates with Treatment Effect on Disability in Multiple Sclerosis
Maria Pia Sormani et al.
ANNALS OF NEUROLOGY (2014)
Anti-JC Virus Antibody Levels in Serum or Plasma Further Define Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Tatiana Plavina et al.
ANNALS OF NEUROLOGY (2014)
Role of the Blood-Brain Barrier in Multiple Sclerosis
Genaro Gabriel Ortiz et al.
ARCHIVES OF MEDICAL RESEARCH (2014)
Relapsing and progressive forms of multiple sclerosis: insights from pathology
Ranjan Dutta et al.
CURRENT OPINION IN NEUROLOGY (2014)
Magnetic resonance outcome measures in multiple sclerosis trials: time to rethink?
Massimo Filippi et al.
CURRENT OPINION IN NEUROLOGY (2014)
Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients
Arumugam Palanichamy et al.
JOURNAL OF IMMUNOLOGY (2014)
A changing treatment landscape for multiple sclerosis: challenges and opportunities
F. Piehl
JOURNAL OF INTERNAL MEDICINE (2014)
N-Acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis
Alessandro Trentini et al.
JOURNAL OF NEUROLOGY (2014)
A practical approach to diagnosing adult onset leukodystrophies
R. M. Ahmed et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron
Lukas Haider et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
Jeremy Chataway et al.
LANCET (2014)
Body fluid biomarkers in multiple sclerosis
Manuel Comabella et al.
LANCET NEUROLOGY (2014)
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
Peter A. Calabresi et al.
LANCET NEUROLOGY (2014)
Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study
Adipong Brickshawana et al.
LANCET NEUROLOGY (2014)
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
Christian Confavreux et al.
LANCET NEUROLOGY (2014)
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
Peter A. Calabresi et al.
LANCET NEUROLOGY (2014)
Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes
Vittorio Martinelli et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis
Divya Narayanan et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
The investigation of acute optic neuritis: a review and proposed protocol
Axel Petzold et al.
NATURE REVIEWS NEUROLOGY (2014)
Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis
Anna Karin Hedstrom et al.
NEUROLOGY (2014)
Epitope spreading as an early pathogenic event in pediatric multiple sclerosis
Francisco J. Quintana et al.
NEUROLOGY (2014)
Defining the clinical course of multiple sclerosis The 2013 revisions
Fred D. Lublin et al.
NEUROLOGY (2014)
Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors
Milena A. Gianfrancesco et al.
OBESITY RESEARCH & CLINICAL PRACTICE (2014)
Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event
Darin T. Okuda et al.
PLOS ONE (2014)
Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis
Arumugam Palanichamy et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
Joel N. H. Stern et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Sleep disorders in multiple sclerosis and their relationship to fatigue
Christian Veauthier et al.
SLEEP MEDICINE (2014)
Urodynamics in the Evaluation of the Patient with Multiple Sclerosis When Are They Helpful and How Do We Use Them?
Benjamin E. Dillon et al.
UROLOGIC CLINICS OF NORTH AMERICA (2014)
miR-155 as a Multiple Sclerosis-Relevant Regulator of Myeloid Cell Polarization
Craig S. Moore et al.
ANNALS OF NEUROLOGY (2013)
Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis
Sofia V. Abrahamsson et al.
BRAIN (2013)
Cortical imaging in multiple sclerosis: recent findings and 'grand challenges'
Marita Daams et al.
CURRENT OPINION IN NEUROLOGY (2013)
IL-17A secretion by CD8(+) T cells supports Th17-mediated autoimmune encephalomyelitis
Magdalena Huber et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Treatment of cognitive impairment in multiple sclerosis: position paper
Maria Pia Amato et al.
JOURNAL OF NEUROLOGY (2013)
Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude
Ruth Dobson et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
B-Cell Enrichment and Epstein-Barr Virus Infection in Inflammatory Cortical Lesions in Secondary Progressive Multiple Sclerosis
Roberta Magliozzi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)
MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials
Maria Pia Sormani et al.
LANCET NEUROLOGY (2013)
CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome
M. Khalil et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome
Timm Oberwahrenbrock et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
Ashley H. Beecham et al.
NATURE GENETICS (2013)
Spinal cord lesions in patients with clinically isolated syndrome A powerful tool in diagnosis and prognosis
Madeleine H. Sombekke et al.
NEUROLOGY (2013)
Epstein-Barr virus in oral shedding of children with multiple sclerosis
Carmen Yea et al.
NEUROLOGY (2013)
Gray matter damage predicts the accumulation of disability 13 years later in MS
Massimo Filippi et al.
NEUROLOGY (2013)
Mortality in patients with multiple sclerosis
Antonio Scalfari et al.
NEUROLOGY (2013)
Grey matter damage in multiple sclerosis A pathology perspective
Roel Klaver et al.
PRION (2013)
Increased CD8+T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis
Daniela F. Angelini et al.
PLOS PATHOGENS (2013)
Transdermal Application of Myelin Peptides in Multiple Sclerosis Treatment
Agata Walczak et al.
JAMA NEUROLOGY (2013)
Relationships Between Retinal Axonal and Neuronal Measures and Global Central Nervous System Pathology in Multiple Sclerosis
Shiv Saidha et al.
JAMA NEUROLOGY (2013)
Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis
Ajit Singh Dhaunchak et al.
ANNALS OF NEUROLOGY (2012)
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis
Sung R. Choi et al.
BRAIN (2012)
Epstein-Barr virus and multiple sclerosis: interaction with HLA
E. Sundqvist et al.
GENES AND IMMUNITY (2012)
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells
Tom A. Barr et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro
Robert P. Lisak et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Patients with migraine do not have MRI-visible cortical lesions
Martina Absinta et al.
JOURNAL OF NEUROLOGY (2012)
Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada
E. Kingwell et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
Jeffrey A. Cohen et al.
LANCET (2012)
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
Alasdair J. Coles et al.
LANCET (2012)
Clinically isolated syndromes
David H. Miller et al.
LANCET NEUROLOGY (2012)
The effect of gender in clinically isolated syndrome (CIS): a meta-analysis
Ruth Dobson et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women
Anna K. Hedstrom et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Effect of gender on late-onset multiple sclerosis
Riley M. Bove et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Progressive multiple sclerosis: pathology and pathogenesis
Hans Lassmann et al.
NATURE REVIEWS NEUROLOGY (2012)
No MRI evidence of cortical lesions in neuromyelitis optica
Massimiliano Calabrese et al.
NEUROLOGY (2012)
Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis
Tim Sinnecker et al.
NEUROLOGY (2012)
Postmortem verification of MS cortical lesion detection with 3D DIR
A. Seewann et al.
NEUROLOGY (2012)
Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis
Rajneesh Srivastava et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Robert J. Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab
Martin Gunnarsson et al.
ANNALS OF NEUROLOGY (2011)
Gestational Vitamin D and the Risk of Multiple Sclerosis in Offspring
Fariba Mirzaei et al.
ANNALS OF NEUROLOGY (2011)
Demyelination Causes Synaptic Alterations in Hippocampi from Multiple Sclerosis Patients
Ranjan Dutta et al.
ANNALS OF NEUROLOGY (2011)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis
Anna Karin Hedstrom et al.
BRAIN (2011)
CD161highCD8+T cells bear pathogenetic potential in multiple sclerosis
Viviana Annibali et al.
BRAIN (2011)
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
Owain W. Howell et al.
BRAIN (2011)
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
A. Novotna et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Cost of disorders of the brain in Europe 2010
Anders Gustavsson et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
Role of gender in multiple sclerosis: Clinical effects and potential molecular mechanisms
Judith M. Greer et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Multiple sclerosis and depression
Anthony Feinstein
MULTIPLE SCLEROSIS JOURNAL (2011)
Cortical lesions in radiologically isolated syndrome
A. Giorgio et al.
NEUROLOGY (2011)
Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
Paul O'Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence
Jorge Ivan Alvarez et al.
SCIENCE (2011)
Abnormal B-Cell Cytokine Responses A Trigger of T-Cell Mediated Disease in MS?
Amit Bar-Or et al.
ANNALS OF NEUROLOGY (2010)
Elevated Epstein-Barr Virus-Encoded Nuclear Antigen-1 Immune Responses Predict Conversion to Multiple Sclerosis
Jan D. Luenemann et al.
ANNALS OF NEUROLOGY (2010)
A Phase 3 Trial of Extended Release Oral Dalfampridine in Multiple Sclerosis
Andrew D. Goodman et al.
ANNALS OF NEUROLOGY (2010)
A Gradient of Neuronal Loss and Meningeal Inflammation in Multiple Sclerosis
Roberta Magliozzi et al.
ANNALS OF NEUROLOGY (2010)
Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple Sclerosis
Laura Piccio et al.
ARCHIVES OF NEUROLOGY (2010)
Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration
Ari J. Green et al.
BRAIN (2010)
The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
Antonio Scalfari et al.
BRAIN (2010)
Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS)
James Twiss et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2010)
Responsiveness of patient-based and external rating scales in multiple sclerosis: Head-to-head comparison in three clinical settings
Stefan M. Gold et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
The changing demographic pattern of multiple sclerosis epidemiology
Nils Koch-Henriksen et al.
LANCET NEUROLOGY (2010)
Emerging effects of comorbidities on multiple sclerosis
Ruth Ann Morrie et al.
LANCET NEUROLOGY (2010)
Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis (vol 9, pg 921, 2010)
A. Petzold et al.
LANCET NEUROLOGY (2010)
Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes
Valentina Zipoli et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Neurofilament light as a prognostic marker in multiple sclerosis
Jonatan Salzer et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
C. Collin et al.
NEUROLOGICAL RESEARCH (2010)
Brainstem lesions in clinically isolated syndromes
M. Tintore et al.
NEUROLOGY (2010)
A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
Gavin Giovannoni et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sleep disorders in patients with multiple sclerosis
Steven D. Brass et al.
SLEEP MEDICINE REVIEWS (2010)
Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis
Axel Petzold et al.
LANCET NEUROLOGY (2010)
Preferential Recruitment of Interferon-γ-Expressing TH17 Cells in Multiple Sclerosis
Hania Kebir et al.
ANNALS OF NEUROLOGY (2009)
Rituximab in Patients with Primary Progressive Multiple Sclerosis Results of a Randomized Double-Blind Placebo-Controlled Multicenter Trial
Kathleen Hawker et al.
ANNALS OF NEUROLOGY (2009)
Smoking and Disease Progression in Multiple Sclerosis
Brian C. Healy et al.
ARCHIVES OF NEUROLOGY (2009)
MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome
Jessica M. Nielsen et al.
BMC NEUROLOGY (2009)
Regulatory T cells fail to suppress CD4+ T-bet+ T cells in relapsing multiple sclerosis patients
Giovanni Frisullo et al.
IMMUNOLOGY (2009)
CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis
Jean M. Fletcher et al.
JOURNAL OF IMMUNOLOGY (2009)
Clinical predictors of early second event in patients with clinically isolated syndrome
Ellen M. Mowry et al.
JOURNAL OF NEUROLOGY (2009)
Responsiveness of patient reported outcome measures in multiple sclerosis relapses: the REMS study
A. Giordano et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord
C. P. Gilmore et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Demyelination, Inflammation, and Neurodegeneration in Multiple Sclerosis Deep Gray Matter
Marco Vercellino et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial
Andrew D. Goodman et al.
LANCET (2009)
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
Eva Havrdova et al.
LANCET NEUROLOGY (2009)
Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score
Philip L. De Jager et al.
LANCET NEUROLOGY (2009)
The development of patient-reported outcome indices for multiple sclerosis (PRIMUS)
L. C. Doward et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci
Philip L. De Jager et al.
NATURE GENETICS (2009)
Clinical prognostic factors in multiple sclerosis: a natural history review
Alexandra Degenhardt et al.
NATURE REVIEWS NEUROLOGY (2009)
A reassessment of the plateauing relationship between T2 lesion load and disability in MS
Maria Pia Sormani et al.
NEUROLOGY (2009)
Remyelination capacity of the MS brain decreases with disease chronicity
T. Goldschmidt et al.
NEUROLOGY (2009)
Disability and T2 MRI lesions:: a 20-year follow-up of patients with relapse onset of multiple sclerosis
L. K. Fisniku et al.
BRAIN (2008)
Compromised CD4(+) CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level
Koen Venken et al.
IMMUNOLOGY (2008)
EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2
Jan D. Luenemann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition
Mark A. Kroenke et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography
F. Costello et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Smoking is a risk factor for early conversion to clinically definite multiple sclerosis
F. Di Pauli et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Remyelination in the CNS: from biology to therapy
Robin J. M. Franklin et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Variants of Multiple Sclerosis
Jack H. Simon et al.
NEUROIMAGING CLINICS OF NORTH AMERICA (2008)
Temporal trends in the incidence of multiple sclerosis
Alvaro Alonso et al.
NEUROLOGY (2008)
The immunology of multiple sclerosis
Amit Bar-Or
SEMINARS IN NEUROLOGY (2008)
Validation of the multiple sclerosis international quality of life questionnaire
M. C. Simeoni et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
A prospective study of patterns of fatigue in multiple sclerosis
A. Lerdal et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Optical coherence tomography and disease subtype in multiple sclerosis
M. Pulicken et al.
NEUROLOGY (2007)
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis
E. Gordon-Lipkin et al.
NEUROLOGY (2007)
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Hania Kebir et al.
NATURE MEDICINE (2007)
Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis
Martin Duddy et al.
JOURNAL OF IMMUNOLOGY (2007)
Psychometric evaluation and calibration of health-related quality of life item banks - Plans for the patient-reported outcomes measurement information system (PROMIS)
Bryce B. Reeve et al.
MEDICAL CARE (2007)
Acute disseminated encephalomyelitis
Silvia Tenembaum et al.
NEUROLOGY (2007)
Extensive cortical remyelination in patients with chronic multiple sclerosis
Monika Albert et al.
BRAIN PATHOLOGY (2007)
Widespread demyelination in the cerebellar cortex in multiple sclerosis
Alexandra Kutzelnigg et al.
BRAIN PATHOLOGY (2007)
Remyelination is extensive in a subset of multiple sclerosis patients
Peter Patrikios et al.
BRAIN (2006)
Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis
Anne L. Astier et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Sex ratio of multiple sclerosis in Canada: a longitudinal study
Sarah-Michelle Orton et al.
LANCET NEUROLOGY (2006)
Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients
Anne H. Cross et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
MRI and the diagnosis of multiple sclerosis: expanding the concept of no better explanation
Arnaud Charil et al.
LANCET NEUROLOGY (2006)
Medical progress: Multiple sclerosis - The plaque and its pathogenesis
EM Frohman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Imaging features of copper deficiency myelopathy: a study of 25 cases
N Kumar et al.
NEURORADIOLOGY (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Cortical demyelination and diffuse white matter injury in multiple sclerosis
A Kutzelnigg et al.
BRAIN (2005)
Modafinil for fatigue in MS - A randomized placebo-controlled double-blind study
B Stankoff et al.
NEUROLOGY (2005)
Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis
NL Monson et al.
ARCHIVES OF NEUROLOGY (2005)
Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions
N Evangelou et al.
BRAIN (2005)
Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing
AJ Mitchell et al.
LANCET NEUROLOGY (2005)
Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis
V Viglietta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
A role of late Epstein-Barr virus infection in multiple sclerosis
S Haahr et al.
ACTA NEUROLOGICA SCANDINAVICA (2004)
Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis
A Minneboo et al.
ARCHIVES OF NEUROLOGY (2004)
The prevalence of pain in multiple sclerosis - A multicenter cross-sectional study
C Solaro et al.
NEUROLOGY (2004)
Elevated neurofilament levels in neurological
N Norgren et al.
BRAIN RESEARCH (2003)
Subpial demyelination in the cerebral cortex of multiple sclerosis patients
L Bo et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process
C Confavreux et al.
BRAIN (2003)
Blood-brain barrier disruption in multiple sclerosis
A Minagar et al.
MULTIPLE SCLEROSIS JOURNAL (2003)
Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis
M Eriksson et al.
MULTIPLE SCLEROSIS JOURNAL (2003)
Mitoxantrone in progressive multiple sclerosis:: a placebo-controlled, double-blind, randomised, multicentre trial
HP Hartung et al.
LANCET (2002)
A longitudinal study of abnormalities on MRI and disability from multiple sclerosis
PA Brex et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Immunopathology of secondary-progressive multiple sclerosis
JW Prineas et al.
ANNALS OF NEUROLOGY (2001)
Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions
JW Peterson et al.
ANNALS OF NEUROLOGY (2001)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Developing a disease-specific quality of life measure for people with multiple sclerosis
HL Ford et al.
CLINICAL REHABILITATION (2001)
Effect of early interferon treatment on conversion to definite multiple sclerosis:: a randomised study
G Comi et al.
LANCET (2001)
The prevalence of multiple sclerosis in the world: an update
G Rosati
NEUROLOGICAL SCIENCES (2001)
分享论文
